Abstract:Rationale: Neurofibromatosis type 1 (NF1) is associated with higher rates of epilepsy compared to the general population. Some NF1 patients with epilepsy do not have intracranial lesions, suggesting the genetic mutation itself may contribute to higher rates of epilepsy in these patients. We have recently demonstrated increased seizure susceptibility in the Nf1+/- mouse, but it is unknown whether this model displays altered epileptogenicity, as has been reported in patients with NF1. The aim of this study was to determine whether the Nf1+/- mouse is more susceptible to electrical kindling-induced epileptogenesis. Methods: Young male or female adult Nf1+/- or Nf1+/+ (wild-type; WT) mice were implanted with electrodes for neocortical or hippocampal kindling paradigms. Neocortical kindling was performed for 40 stimulation sessions followed by baseline EEG monitoring to detect possible SRSs. Hippocampal kindling was performed with a modified extended kindling paradigm, completed to a maximum of 80 sessions to try to induce spontaneous repetitive seizures (SRSs). Western blot assays were performed in naïve and kindled mice to compare levels of Akt and MAPK (ERK1/2), proteins downstream of the NF1 mutation. Results: The average initial neocortical after-discharge threshold (ADT) was significantly lower in the Nf1+/- group, which also required fewer stimulations to reach stage 5 seizure, had greater average seizure severity across all kindling sessions, had a greater number of convulsive seizures, and had a faster progression of after-discharge duration and Racine score during kindling. No WT mice exhibited SRS after neocortical kindling, versus 33% of Nf1+/- mice. The average initial hippocampal ADT was not significantly different between the WT and Nf1+/- groups, nor was there a difference in the number of stimulations required to reach the kindled state. The WT group had a significantly higher average seizure severity across all kindling sessions as compared with the Nf1+/- mice. The WT group also had faster progression of the Racine seizure score over the kindling sessions, mainly due to a faster increase in seizures severity early during the kindling process. However, SRSs were seen in 50% of Nf1+/- mice after modified extended kindling and in no WT mice. Western blots showed hippocampal kindling increased the ratio of phosphorylated/total Akt in both the WT and Nf1+/- mice, while neocortical kindling led to increased ratios of phosphorylated/total Akt and MAPK in Nf1+/- mice only. Conclusions: We have demonstrated for the first time an increased rate of epileptogenesis in an animal model of NF1 with no known macroscopic/neoplastic brain lesions. This work provides evidence for the genetic mutation itself playing a role in seizures and epilepsy in patients with NF1, and supports the use of the Nf1+/- mouse model in future mechanistic studies.

Pheochromocytomas in Nf1 Knockout Mice Express a Neural Progenitor Gene Expression Profile.

Functional Characterization Of Pulmonary Neuroendocrine Cells In Lung Development, Injury, And Tumorigenesis

PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.

Spatial gene expression profiling unveils immuno-oncogenic programs of NF1-associated peripheral nerve sheath tumor progression

Conditional deletion of Pten tumor suppressor gene and activation of K Ras oncogene result in the development of Neurofibromatoses

Expression of Pituitary Tumor Transforming Gene-1 Proto-Oncogene is Upregulated in the Brain of Neuronal-Specific Neural Salient Serine/Arginine Rich Protein-1 Gene Knockout Mice

Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1

Abstract C10: Neural Stem Cells and Lineage-Restricted Progenitors Can Initiate Malignant Astrocytoma Formation in Somatic Tumor Suppressor Mouse Models

Conditional Pten Knock-Out Mice: A Model For Metastatic Phaeochromocytoma

Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1

Molecular markers of neuroendocrine development and evidence of environmental regulation.

Mice Lacking Neurofibromin Develop Gastric Hyperplasia

Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas

N-myc Alters the Fate of Preneoplastic Cells in a Mouse Model of Medulloblastoma.

Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction

Treatment of Pheochromocytoma Blockade of MAPK Pathway Inhibition in the NF-κB Pathway and Bfgf — Effect of Statins on Pheochromocytoma Patients

Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma

Hyperactivation of P21ras and PI3K Cooperate to Alter Murine and Human Neurofibromatosis Type 1-Haploinsufficient Osteoclast Functions.

Increased epileptogenicity in a mouse model of neurofibromatosis type 1

Pigment epithelium derived factor drives melanocyte proliferation and migration in neurofibromatosis café au lait macules

A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor